近日,北京证券交易所披露终止审核公告,上海延安医药洋浦股份有限公司(下称“延安医药”)再次撤回北交所上市申请。 根据北交所披露的信息,因延安医药向北交所提交了《上海延安医药洋浦股份有限公司关于撤回向不特定合格投资者公开发行股票并在北京证券交易所上市申请文件的申请》,北交所决定终止其公开发行股票并在北京证券交易所上市的审核。 这已是延安医药第二次终止北交所IPO进程。根据北交所项目动态信息,...
Source Link近日,北京证券交易所披露终止审核公告,上海延安医药洋浦股份有限公司(下称“延安医药”)再次撤回北交所上市申请。 根据北交所披露的信息,因延安医药向北交所提交了《上海延安医药洋浦股份有限公司关于撤回向不特定合格投资者公开发行股票并在北京证券交易所上市申请文件的申请》,北交所决定终止其公开发行股票并在北京证券交易所上市的审核。 这已是延安医药第二次终止北交所IPO进程。根据北交所项目动态信息,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.